Naomi Oi

1.0k total citations
25 papers, 748 citations indexed

About

Naomi Oi is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Naomi Oi has authored 25 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Organic Chemistry. Recurrent topics in Naomi Oi's work include Inflammatory mediators and NSAID effects (6 papers), Synthesis and biological activity (4 papers) and Phytochemicals and Antioxidant Activities (4 papers). Naomi Oi is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Synthesis and biological activity (4 papers) and Phytochemicals and Antioxidant Activities (4 papers). Naomi Oi collaborates with scholars based in United States, China and Japan. Naomi Oi's co-authors include Zigang Dong, Ann M. Bode, Hanyong Chen, Myoung Ok Kim, Ronald A. Lubet, Janos Nadas, Kazuki Kanazawa, Takashi Hashimoto, Feng Zhu and Yong‐Yeon Cho and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Naomi Oi

24 papers receiving 738 citations

Peers

Naomi Oi
Phillip J. Daschner United States
Ji‐Ye Kee South Korea
Youn Kyung Choi South Korea
Velmurugan Balaiya United States
Avantika Barve United States
Phillip J. Daschner United States
Naomi Oi
Citations per year, relative to Naomi Oi Naomi Oi (= 1×) peers Phillip J. Daschner

Countries citing papers authored by Naomi Oi

Since Specialization
Citations

This map shows the geographic impact of Naomi Oi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Oi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Oi more than expected).

Fields of papers citing papers by Naomi Oi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Oi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Oi. The network helps show where Naomi Oi may publish in the future.

Co-authorship network of co-authors of Naomi Oi

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Oi. A scholar is included among the top collaborators of Naomi Oi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Oi. Naomi Oi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Xueli, Kangdong Liu, Zhi Li, et al.. (2019). 3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2. Cancer Letters. 448. 20–30. 36 indexed citations
2.
Zhang, Tianshun, Qiushi Wang, Ge Gao, et al.. (2018). The Ashitaba ( Angelica keiskei ) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Cancer Prevention Research. 11(10). 607–620. 11 indexed citations
3.
Yamamoto, Hiroyuki, Joohyun Ryu, Naomi Oi, et al.. (2017). TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis. Journal of Investigative Dermatology. 137(6). 1322–1332. 15 indexed citations
4.
Sheng, Yuqiao, Kangdong Liu, Qiong Wu, et al.. (2016). PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts. Oncotarget. 7(21). 30977–30989. 3 indexed citations
5.
Li, Haitao, Feng Zhu, Lisa A. Boardman, et al.. (2015). Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression. EBioMedicine. 2(5). 447–455. 29 indexed citations
6.
Li, Haitao, Feng Zhu, Hanyong Chen, et al.. (2015). Abstract 4573: 6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1. Cancer Research. 75(15_Supplement). 4573–4573.
7.
Oi, Naomi, Jian Yuan, Margarita Malakhova, et al.. (2014). Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene. 34(20). 2660–2671. 55 indexed citations
8.
Sheng, Yuqiao, Wěi Li, Feng Zhu, et al.. (2014). 3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer. Journal of Biological Chemistry. 289(41). 28192–28201. 19 indexed citations
9.
Li, Haitao, Kangdong Liu, Lisa A. Boardman, et al.. (2014). Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance. EBioMedicine. 2(2). 165–171. 24 indexed citations
10.
Li, Haitao, Feng Zhu, Yanwen Sun, et al.. (2013). Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2. PLoS ONE. 8(10). e76452–e76452. 4 indexed citations
11.
Kim, Myoung Ok, Mee‐Hyun Lee, Naomi Oi, et al.. (2013). [6]-Shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis. 35(3). 683–691. 79 indexed citations
12.
Oi, Naomi, Hanyong Chen, Myoung Ok Kim, et al.. (2012). Taxifolin Suppresses UV-Induced Skin Carcinogenesis by Targeting EGFR and PI3K. Cancer Prevention Research. 5(9). 1103–1114. 72 indexed citations
13.
Li, Xiang, Haitao Li, Shengqing Li, et al.. (2012). Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B. Carcinogenesis. 33(12). 2548–2557. 25 indexed citations
14.
Chen, Hanyong, Ke Yao, Janos Nadas, et al.. (2012). Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods. PLoS ONE. 7(5). e38261–e38261. 36 indexed citations
15.
Kim, Myoung Ok, Sunghyun Kim, Naomi Oi, et al.. (2011). Embryonic stem‐cell‐preconditioned microenvironment induces loss of cancer cell properties in human melanoma cells. Pigment Cell & Melanoma Research. 24(5). 922–931. 19 indexed citations
16.
Oi, Naomi, Chul‐Ho Jeong, Janos Nadas, et al.. (2010). Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase. Cancer Research. 70(23). 9755–9764. 79 indexed citations
17.
Oi, Naomi, Takashi Hashimoto, Fumiki Aoki, et al.. (2007). Absorption of Dietary Licorice Isoflavan Glabridin to Blood Circulation in Rats. Journal of Nutritional Science and Vitaminology. 53(4). 358–365. 33 indexed citations
18.
Hashimoto, Takashi, et al.. (2007). Yellow tea is more potent than other types of tea in suppressing liver toxicity induced by carbon tetrachloride in rats. Phytotherapy Research. 21(7). 668–670. 30 indexed citations
19.
Oi, Naomi, Takashi Hashimoto, & Kazuki Kanazawa. (2007). Metabolic Conversion of Dietary Quercetin from Its Conjugate to Active Aglycone Following the Induction of Hepatocarcinogenesis in Fisher 344 Rats. Journal of Agricultural and Food Chemistry. 56(2). 577–583. 12 indexed citations
20.
Hashimoto, Takashi, Yuko Ueda, Naomi Oi, et al.. (2006). Effects of Combined Administration of Quercetin, Rutin, and Extract of White Radish Sprout Rich in Kaempferol Glycosides on the Metabolism in Rats. Bioscience Biotechnology and Biochemistry. 70(1). 279–281. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026